Page last updated: 2024-08-17

medroxyprogesterone acetate and Kidney Failure, Chronic

medroxyprogesterone acetate has been researched along with Kidney Failure, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chi, HS; Jung, HH; Kim, SB; Min, WK; Park, JS; Yang, WS	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Kidney Failure, Chronic

Article	Year
Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:11 Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Renal Dialysis; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor	2000

Article

Year

Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:11

Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Renal Dialysis; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor

2000